![](https://endpts.com/wp-content/uploads/2020/07/Adrian-Gottschalk-Foghorn-tile-scaled.jpg)
Adrian Gottschalk, Foghorn CEO (Foghorn)
Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing
It’s been a record year for biotech IPOs, and the execs at Nasdaq would like nothing better than to see that momentum continue …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.